Bowel perforation from bevacizumab for the treatment of metastatic colon cancer: incidence, etiology, and management (Q80257767)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 September 2006
edit
Language Label Description Also known as
English
Bowel perforation from bevacizumab for the treatment of metastatic colon cancer: incidence, etiology, and management
scientific article published on 01 September 2006

    Statements

    Bowel perforation from bevacizumab for the treatment of metastatic colon cancer: incidence, etiology, and management (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit